Funding and support

The Editoral Base of Cochrane Haematology (CH)  is funded under the auspices of the German Federal Ministry of Education and Research (BMBF), Deutsche Krebshilfe e.V.,  European Heamatology Association (EHA), Institute for Quality and Efficiency in Healthcare (IQWIG)European Respiratory Society (ERS)World Health Organization (WHO)Deutschen Forschungsgemeinschaft (DFG), in addition by the funding programme Köln Fortune from the medical faculty University of Cologne.

The following projects are currently funded by the German Federal Ministry of Education and Research:

  • First-line therapy for adult patients with advanced renal cell carcinoma: a living systematic review (BMBF grant application, No: 01KG1901)

  • Interventions to treat fatigue in adult cancer patients: a Cochrane systematic review with meta-analysis (BMBF grant application, No: 01KG2017)

  • Physical Intervention for patients with Morbus Parkinson: A systematic review with network meta analysis (BMBF grant, No: 01KG1902)

  • Vaccines for cancer patients: a Cochrane systematic review with meta-analyses (BMBF grant, No: KS2020-143)

Within the framework of the BMBF-funded National University Medicine Research Network (NUM), the following projects are being carried out:

  • Establishment of a COVID-19 evidence ecosystem to improve knowledge management and translation (CEOsys) in collaboration with cooperation partners (BMBF funded; FKZ: 01KX2021).

  • Determination and use of SARS-CoV-2 immunity (COVIM) in collaboration with cooperation partners (BMBF funded; FKZ: 01KX2021)

The following projects are funded by the German Cancer Aid:

  • Update of the interdisciplinary evidence-based guideline for Hodgkin´s Lymphoma in Adults, diagnosis, treatment and follow-up (Funding provided by the German Cancer Aid)

  • Interdisciplinary evidence-based guideline for diagnosis, therapy and follow-up of multiple myeloma patients (Funding provided by the German Cancer Aid)

  • Interdisciplinary evidence-based guideline for diagnosis, therapy and follow-up of mature patients with diffuse large B-cell-lymphoma (Funding provided by the German Cancer Aid)

The following project is currently funded by the EHA:

  • Antifungal prophylaxis and therapy in patients with acute myeloid leukaemia treated with new agents (Funding provided by the EHA)

  • Standards in the use and reporting of patient-reported outcomes (EHA-Pro)

The following projects are currently funded by the DFG:

  • Assessment of the current state of consideration of the specificity of time-to-event analyses in meta-analyses: re-analysis of systematic reviews and implementation of action guidance (SK 146/2-1)

  • Enhancing the willingness of healthcare workers to be vaccinated against COVID-19 in Germany (SK 146/3-1)

The following project is currently funded by the NIHR:

  • „SUPPORT-E“: Supporting high quality evaluation of COVID-19 convalescent plasma throughout Europe (funded by the European Union's Horizon 2020 research and innovation programme)